See Scientist To Watch Phil Baran describe the artistry of his research in drug discovery.
By Abby Olena | February 1, 2014
Read the full story.
Sign In with your LabX Media Group Passport to leave a comment
Not a member? Register Now!
By Tracy Vence
Meanwhile, Allergan acquires drug developer Naurex in a $560 million deal.
By Jef Akst
The European Medicines Agency endorses the first-ever malaria vaccine for use in children 6 weeks to 17 months old.
The US Department of Health and Human Services will put nearly $20 million toward the development of an Ebola drug as Tekmira steps out of the space.
Kepler-452b revolves around a sun much like our own.
Multiple consecutive adenosine nucleotides can cause protein translation machinery to stall on messenger RNAs.
Researchers discover an unprecedented paleontological relic that may just rewrite the book on snake evolution.
Putting the microbiome front and center in health care, in preventive strategies, and in health-risk assessments could stem the epidemic of noncommunicable diseases.
View the August 2015 contents.
© 1986-2015 The Scientist